Atosiban for threatened preterm birth: the APOSTEL 8 trial - Authors' reply. van der Windt LI, Oudijk MA. Lancet 2025;406:1339-1340.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

van der Windt LI, Oudijk MA. Atosiban for threatened preterm birth: the APOSTEL 8 trial - Authors' reply. Lancet 2025;406:1339-1340.
PMID: 41015520